Participation in clinical trials is an independent prognostic factor of breast cancer treatment

被引：0
|
作者：
Bilynskyy, B. [1 ]
Shparyk, J. [1 ]
Kachmar, T. [1 ]
Lukavetskyy, N. [1 ]
机构：
[1] Med Univ Lemberg, Klin Oncol, Lvov, Ukraine
来源：
ONKOLOGIE | 2011年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：61 / 61
页数：1
相关论文
共 50 条
  • [31] Barriers and effective interventions to engage Latinas' participation in breast cancer clinical trials
    Padilla, Monica J.
    Karczmar, Gregory
    CANCER RESEARCH, 2023, 83 (07)
  • [32] Patient education intervention to improve breast cancer clinical trials participation.
    Shafaee, Maryam Nemati
    Simmons, Kristen
    Podany, Emily L.
    Hernandez-Herrera, Anadulce
    Hoyos, Valentina
    Henry, Giselle
    Sanchez, Daisy
    Coronel, Cristina
    Hildebrandt, Rebecca
    Bulsara, Shaun
    Hilsenbeck, Susan G.
    Niravath, Polly Ann
    Badr, Hoda
    Ellis, Matthew James
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18532 - E18532
  • [33] Does participation in clinical trials influence on survival in patients with metastatic breast cancer?
    Kim, T-Y
    Sohn, J. H.
    Kim, S-B
    Yoon, J. H.
    Kim, G. M.
    Lee, K. H.
    Koh, S-J
    Park, Y. H.
    Lee, S. E.
    Chae, Y.
    Lee, K. S.
    Lee, K. E.
    Won, H. S.
    Kim, J. H.
    Jeong, J.
    Park, K. H.
    Cho, E. K.
    Im, Y-H
    Im, S-A
    Jung, K. H.
    CANCER RESEARCH, 2016, 76
  • [34] Treatment of advanced ovarian cancer in Germany: The impact of participation in clinical trials
    du Bois, A
    Pfisterer, J
    Kellermann, L
    Kreienberg, R
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2001, 61 (11) : 863 - 871
  • [35] Histological type is not an independent prognostic factor for the risk pattern of breast cancer recurrences
    Kwast, Annemiek B. G.
    Groothuis-Oudshoorn, Karin C. G. M.
    Grandjean, Ilse
    Ho, Vincent K. Y.
    Voogd, Adri C.
    Menke-Pluymers, Marian B. E.
    van der Sangen, Maurice J. C.
    Tjan-Heijnen, Vivianne C. G.
    Kiemeney, Lambertus A.
    Siesling, Sabine
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 135 (01) : 271 - 280
  • [36] Infiltration by myeloperoxidase-positive neutrophils is an independent prognostic factor in breast cancer
    Zeindler, Jasmin
    Angehrn, Fiorenzo
    Droeser, Raoul
    Daester, Silvio
    Piscuoglio, Salvatore
    Ng, Charlotte K. Y.
    Kilic, Ergin
    Mechera, Robert
    Meili, Samuel
    Isaak, Andrej
    Weber, Walter P.
    Muenst, Simone
    Soysal, Savas Deniz
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 177 (03) : 581 - 589
  • [37] NDRG1 Expression Is an Independent Prognostic Factor in Inflammatory Breast Cancer
    Villodre, Emilly S.
    Gong, Yun
    Hu, Xiaoding
    Huo, Lei
    Yoon, Esther C.
    Ueno, Naoto T.
    Woodward, Wendy A.
    Tripathy, Debu
    Song, Juhee
    Debeb, Bisrat G.
    CANCERS, 2020, 12 (12) : 1 - 14
  • [38] NDRG1 expression is an independent prognostic factor in inflammatory breast cancer
    Villodre, Emilly Schlee
    Gong, Yun
    Hu, Xiaoding
    Huo, Lei
    Yoon, Esther C.
    Ueno, Naoto T.
    Woodward, Wendy A.
    Tripathy, Debu
    Song, Juhee
    Debeb, Bisrat G.
    CANCER RESEARCH, 2022, 82 (04)
  • [39] 8-Hydroxydeoxyguanosine: a new potential independent prognostic factor in breast cancer
    H Sova
    A Jukkola-Vuorinen
    U Puistola
    S Kauppila
    P Karihtala
    British Journal of Cancer, 2010, 102 : 1018 - 1023
  • [40] LKB1 expression is an independent prognostic factor for breast cancer patients
    Sueta, Aiko
    Fujiki, Yoshitaka
    Tomiguchi, Mai
    Takeshita, Takashi
    Ibusuki, Mutsuko
    Yamamoto, Yutaka
    Iwase, Hirotaka
    CANCER SCIENCE, 2018, 109 : 522 - 522
12345